ClinicalTrials.Veeva

Menu

Exploring the Genetics of Neuropathic Pain (GeNeup)

University of Oslo (UIO) logo

University of Oslo (UIO)

Status

Enrolling

Conditions

Polyneuropathies
Genetic Predisposition
Neuropathic Pain

Treatments

Genetic: Nerve conduction Studies

Study type

Observational

Funder types

Other

Identifiers

NCT03862365
2017/1593

Details and patient eligibility

About

In the present study the investigators will search for new genetic variants relevant for the development of neuropathic pain.

Full description

Neuropathic pain is defined as "pain caused by a lesion or disease of the somatosensory nervous system". Neuropathic pain is a huge health problem worldwide, with an estimated prevalence of 7-8 % in the general population. In the present study the investigators will search for new genetic variants relevant for the development of this type of pain.

Peripheral nerve lesions only progress to neuropathic pain in some patients, yet is not completely understood why or how. Genetic studies of patients with rare neuropathic disorders have been important for elucidating novel molecular mechanisms of neuropathic pain, and new drugs for neuropathic pain are now being developed based on these findings. By using genetic association studies, one may identify new genetic variants which may help to identify key molecular mechanisms for a larger group of patients with neuropathic pain.

This project will use existing population-based cohorts, as well as establish a specific registry and biobank for patients with neuropathy in order to address these specific needs. This will allow the investigators to identify a large number of individuals with probable neuropathic pain and individuals with pain-free peripheral neuropathy (disease controls). International collaboration will contribute to study a large group of patients, which will be important in order to reach the project's goals. The results from the project are expected to increase current knowledge on the mechanisms of neuropathic pain, opening up new opportunities for innovative and improved treatments.

Dissemination of results will be organized in close collaboration with patient representatives, and will be done regularly throughout the course of the project. The will focus both on internal dissemination to the participating hospitals, and external dissemination through participation in conferences, submissions to scientific journals and by publishing patient-friendly information booklets and proactively informing media outlets and patient organizations.

Enrollment

5,000 estimated patients

Sex

All

Ages

18 to 70 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. The patient is between 18 and 70 years old.
  2. The patient has consented.
  3. The patient is referred for evaluation of possible distal symmetric polyneuropathy (DSPN).
  4. The patient has filled out the questionnaires.

Exclusion criteria

  1. The patient is too sick to participate (eg. bedridden, fever).
  2. The patient is unable to consent (eg. dementia, speech problems, psychiatric disorder).
  3. Inflammatory acute polyneuropathy.

Trial design

5,000 participants in 6 patient groups

Polyneuropathy with pain
Description:
Clinical and diagnostic test evaluation for the establishment of polyneuropathy with pain.
Treatment:
Genetic: Nerve conduction Studies
Polyneuropathy without pain
Description:
Clinical and diagnostic test evaluation for the establishment of polyneuropathy without pain.
Treatment:
Genetic: Nerve conduction Studies
Diabetic polyneuropathy with pain
Description:
Clinical and diagnostic test evaluation for the establishment of diabetic polyneuropathy with pain.
Treatment:
Genetic: Nerve conduction Studies
Diabetic polyneuropathy without pain
Description:
Clinical and diagnostic test evaluation for the establishment of diabetic polyneuropathy without pain.
Treatment:
Genetic: Nerve conduction Studies
Carpal tunnel syndrome with pain
Description:
Clinical and diagnostic test evaluation for the establishment of carpal tunnel syndrome with pain.
Treatment:
Genetic: Nerve conduction Studies
Carpal tunnel syndrome without pain
Description:
Clinical and diagnostic test evaluation for the establishment of carpal tunnel syndrome without pain.
Treatment:
Genetic: Nerve conduction Studies

Trial contacts and locations

5

Loading...

Central trial contact

Kristian B. Nilsen, M.D

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems